Dallas, TX: ReportsandReports announce it will carry Taiwan In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.
Browse complete Taiwan In Vitro Diagnostics Market Outlook to 2016 Report
GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Taiwan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Taiwan In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Taiwan In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 In Vitro Diagnostics In Taiwan 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19
3.4 In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20
3.5 In Vitro Diagnostics, Taiwan, Company Share (2008-2009) 26
4 Clinical Chemistry In Taiwan 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, Taiwan, Company Share (2008-2009) 44
5 Genetic Testing In Taiwan 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, Taiwan, Company Share (2008-2009) 54
6 Haematology In Taiwan 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, Taiwan, Revenue Mix ($m), 2009 56
6.3 Haematology Market, Taiwan, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 65
6.4.3 Haemostasis Revenue (2002-2016) 67
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 71
6.4.5 Haematology Cell Counters Revenue (2002-2016) 74
6.5 Haematology Distribution Share (2008-2009) 76
6.6 Haematology, Taiwan, Company Share (2008-2009) 77
7 Histology And Cytology In Taiwan 79
7.1 Histology and Cytology, Market Segmentation 79
7.2 Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80
7.3 Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81
7.4 Histology and Cytology Overall Revenue (2002-2016) 82
7.4.1 Histology Revenue (2002-2016) 85
7.5 Histology And Cytology Distribution Share (2008-2009) 88
7.6 Histology And Cytology, Taiwan, Company Share (2008-2009) 89
8 Immuno Chemistry In Taiwan 90
8.1 Immuno Chemistry, Market Segmentation 90
8.2 Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91
8.3 Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92
8.4 Immuno Chemistry Overall Revenue (2002-2016) 93
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 97
8.4.2 Drug Related Testing Revenue (2002-2016) 101
8.4.3 Endocrinology Tests Revenue (2002-2016) 103
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 107
8.5 Immuno Chemistry Distribution Share (2008-2009) 111
8.6 Immuno Chemistry, Taiwan, Company Share (2008-2009) 112
9 Infectious Immunology In Taiwan 114
9.1 Infectious Immunology, Market Segmentation 114
9.2 Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115
9.3 Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116
9.4 Infectious Immunology Overall Revenue (2002-2016) 117
9.5 Infectious Immunology Distribution Share (2008-2009) 121
9.6 Infectious Immunology, Taiwan, Company Share (2008-2009) 122
10 Microbiology Culture In Taiwan 124
10.1 Microbiology Culture, Market Segmentation 124
10.2 Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125
10.3 Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126
10.4 Microbiology Culture Overall Revenue (2002-2016) 127
10.4.1 Microbiology Analyzers Revenue (2002-2016) 131
10.5 Microbiology Culture Distribution Share (2008-2009) 133
10.6 Microbiology Culture, Taiwan, Company Share (2008-2009) 134
11 Overview of Key Companies in Taiwan In Vitro Diagnostics Market 135
11.1 F. Hoffmann-La Roche Ltd. 135
11.1.1 Company Overview 135
11.1.2 Share in the Taiwan In Vitro Diagnostics Market 135
11.2 Siemens Healthcare 136
11.2.1 Company Overview 136
11.2.2 Share in the Taiwan In Vitro Diagnostics Market 136
11.3 Beckman Coulter, Inc. 137
11.3.1 Company Overview 137
11.3.2 Share in the Taiwan In Vitro Diagnostics Market 137
11.4 Ortho-Clinical Diagnostics Inc. 138
11.4.1 Company Overview 138
11.4.2 Share in the Taiwan In Vitro Diagnostics Market 138
11.5 Abbott Laboratories 139
11.5.1 Company Overview 139
11.5.2 Share in the Taiwan In Vitro Diagnostics Market 139
11.6 bioMerieux S.A. 140
11.6.1 Company Overview 140
11.6.2 Share in the Taiwan In Vitro Diagnostics Market 140
11.7 Inverness Medical Innovations, Inc. 141
11.7.1 Company Overview 141
11.8 Becton, Dickinson and Company 141
11.8.1 Company Overview 141
11.9 Bio-Rad Laboratories, Inc. 142
11.9.1 Company Overview 142
11.10 Hologic, Inc. 142
11.10.1 Company Overview 142
11.11 OLYMPUS CORPORATION 143
11.11.1 Company Overview 143
11.12 Mindray Medical International Limited 143
11.12.1 Company Overview 143
11.13 Sysmex Corporation 144
11.13.1 Company Overview 144
11.14 Ventana Medical Systems, Inc. 144
11.14.1 Company Overview 144
11.15 DiaSorin S.p.A 144
11.15.1 Company Overview 144
11.16 Qiagen N.V. 145
11.16.1 Company Overview 145
11.17 Gen-Probe Incorporated 145
11.17.1 Company Overview 145
11.18 Phadia AB 145
11.18.1 Company Overview 145
11.19 BioCare Corporation 146
11.19.1 Company Overview 146
11.20 AsiaGen Corporation 146
11.20.1 Company Overview 146
11.21 Oncoprobe Biotech Inc. 146
11.21.1 Company Overview 146
11.22 Exploit Technologies Pte Ltd 147
11.22.1 Company Overview 147
11.23 Apex Biotechnology Corp. 147
11.23.1 Company Overview 147
11.24 Health & Life Co., Ltd. 147
11.24.1 Company Overview 147
11.25 Eumed Biotechnology Co., Ltd. 148
11.25.1 Company Overview 148
11.26 Vita Genomics, Inc. 148
11.26.1 Company Overview 148
11.27 Formosa Biomedical Technology Corp. 148
11.27.1 Company Overview 148
12 In Vitro Diagnostics Market Pipeline Products 149
12.1 Clinical Chemisty Market Pipeline Products 149
12.2 Immuno Chemistry Market Pipeline Products 151
12.3 Haematology Market Pipeline Products 152
12.4 Infectious Immunology Market Pipeline Products 153
12.5 Microbiology Culture Market Pipeline Products 155
12.6 Histology and Cytology Market Pipeline Products 156
12.7 Genetic Testing Market Pipeline Products 157
13 Financial Deals Landscape 159
13.1 Partnerships 159
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 159
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 160
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161
13.1.4 TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163
13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164
13.1.7 DxS Signs Cross-Licensing Agreement With Epigenomics 165
14 Appendix 166
14.1 Definitions of Markets Covered in the Report 167
14.1.1 In Vitro Diagnostics 167
14.2 Research Methodology 174
14.3 Secondary Research 175
14.4 Primary Research 175
14.5 Models 176
14.6 Forecasts 176
14.7 Expert Panels 176
14.8 GlobalData Consulting 176
14.9 Currency Conversion 177
14.10 Contact Us 177
14.11 Disclaimer 177
Browse complete Taiwan In Vitro Diagnostics Market Outlook to 2016 Report
Browse all Medical Devices Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Latest Report
Related Reports:
Taiwan Diagnostic Imaging Market Outlook to 2016
South Africa In Vitro Diagnostics Market Outlook to 2016
Japan In Vitro Diagnostics Market Outlook to 2016
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
